Novel prognostic prediction models for patients with stage IV colorectal cancer after concurrent curative resection.

about

Primary tumor resection in stage IV unresectable colorectal cancer: what has changed?

P2860

Q47133665-CBB380F4-69AD-4980-99BA-9E703900FDCC

P2860

Novel prognostic prediction models for patients with stage IV colorectal cancer after concurrent curative resection.

Item

http://www.wikidata.org/entity/Q54863313

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Novel prognostic prediction mo ...... concurrent curative resection.

@en

Novel prognostic prediction mo ...... concurrent curative resection.

@nl

type

Item

label

Novel prognostic prediction mo ...... concurrent curative resection.

@en

Novel prognostic prediction mo ...... concurrent curative resection.

@nl

prefLabel

Novel prognostic prediction mo ...... concurrent curative resection.

@en

Novel prognostic prediction mo ...... concurrent curative resection.

@nl

P1476

Novel prognostic prediction mo ...... concurrent curative resection.

@en

P2093

H Akita

http://www.w3.org/2001/XMLSchema#string

H Takahashi

http://www.w3.org/2001/XMLSchema#string

J Okami

http://www.w3.org/2001/XMLSchema#string

K Gotoh

http://www.w3.org/2001/XMLSchema#string

K Sugimura

http://www.w3.org/2001/XMLSchema#string

M Higashiyama

http://www.w3.org/2001/XMLSchema#string

M Ohue

http://www.w3.org/2001/XMLSchema#string

M Yano

http://www.w3.org/2001/XMLSchema#string

M Yasui

http://www.w3.org/2001/XMLSchema#string

N Miyoshi

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Cancer statistics, 2014

Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study

Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.

Prognostic nomograms for predicting survival and distant metastases in locally advanced rectal cancers

Evaluating the yield of medical tests.

PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic color

The beneficial effect of palliative resection in metastatic colorectal cancer.

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer.

P304

e000052

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ESMOOPEN-2016-000052

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27843609

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5070303

http://www.w3.org/2001/XMLSchema#string

Novel prognostic prediction models for patients with stage IV colorectal cancer after concurrent curative resection.

about

P2860

P2860

Novel prognostic prediction models for patients with stage IV colorectal cancer after concurrent curative resection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932